OSOK Insider Trading Activity and SEC Form 4 Filings
OSOK insider trading summary
No open-market insider purchases or sales of NEUROONE MEDICAL TECHNOLOGIES Corp (OSOK) have been reported on SEC Form 4 in the past 12 months.
Latest OSOK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 19, 2017 | Amer Samad | Chief Executive Officer | Buy | $502 (15,728 @ $0.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.